← Leaderboards
Martin Kaczocha
State University Of New York At Buffalo
$9,793,941
Attributed
$13,794,115
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2011–25$2.5M$1.9M$1.3M$625K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,794,115 · 8
By mechanism
R01$12,725,708 · 6
R56$679,145 · 1
R21$389,262 · 1
Top collaborators
- Samir Haj-Dahmane5 shared
- Iwao Ojima5 shared
- Robert C. Rizzo5 shared
- Lloyd C Trotman5 shared
Most similar at State University Of New York At Buffalo
Same institution · by research overlap
- Samir Haj-Dahmane$5,888,197
Others in their field
Top investigators on “Enzymes”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,577,666
- Randall J Bateman · Washington University$83,824,814
- Stuart L Schreiber · Harvard University (Medical School)$49,424,554
- Jay D Keasling · University Of California-Berkeley$47,558,861
- David Heimbrook · Leidos Biomedical Research, Inc.$47,513,682
- Susan Abushakra · Alzheon, Inc.$47,265,244
Research focus
EnzymesLeadCellsEndocannabinoidsFatty Acid-Binding ProteinsLipidsSignal TransductionMediatingCannabinoid ReceptorPainIn VitroOutcome StudyProteinsAnalgesicsReceptorPositioning AttributeMetabolismKnockout MiceFoundationsChronic PainAddictionInflammatory PainIn VivoAbsence Of Pain Sensation
Grant awards (28)
FABP5: Novel Functions in Pain Modulation$504,415
R01 · FY2025 · NS · contact PI
Development of the Next Generation of FABP5 Inhibitors to Treat Prostate Cancer$629,362
R01 · FY2024 · CA
Synaptic transport of endocannabinoids in the brain$603,036
R01 · FY2024 · MH
FABP5: Novel functions in pain modulation$493,279
R01 · FY2024 · NS · contact PI
Endocannabinoid Metabolism in Acute Pain$461,057
R01 · FY2024 · DA · contact PI
Development of the Next Generation of FABP5 Inhibitors to Treat Prostate Cancer$654,000
R01 · FY2023 · CA
Synaptic transport of endocannabinoids in the brain$531,251
R01 · FY2023 · MH
Endocannabinoid Metabolism in Acute Pain$461,057
R01 · FY2023 · DA · contact PI
Development of the Next Generation of FABP5 Inhibitors to Treat Prostate Cancer$658,627
R01 · FY2022 · CA
Synaptic transport of endocannabinoids in the brain$583,581
R01 · FY2022 · MH
Endocannabinoid Metabolism in Acute Pain$461,057
R01 · FY2022 · DA · contact PI
FABPs: Novel Roles in Pain and Inflammation$395,451
R01 · FY2022 · DA · contact PI
Development of the Next Generation of FABP5 Inhibitors to Treat Prostate Cancer$676,650
R01 · FY2021 · CA
Synaptic transport of endocannabinoids in the brain$631,416
R01 · FY2021 · MH
Endocannabinoid Metabolism in Acute Pain$461,057
R01 · FY2021 · DA · contact PI
FABPs: Novel Roles in Pain and Inflammation$395,451
R01 · FY2021 · DA · contact PI
Development of the Next Generation of FABP5 Inhibitors to Treat Prostate Cancer$695,974
R01 · FY2020 · CA
Synaptic transport of endocannabinoids in the brain$679,145
R56 · FY2020 · MH
Endocannabinoid Metabolism in Acute Pain$461,057
R01 · FY2020 · DA · contact PI
FABPs: Novel Roles in Pain and Inflammation$395,451
R01 · FY2020 · DA · contact PI
FABPs: Novel Roles in Pain and Inflammation$395,451
R01 · FY2019 · DA · contact PI
Anandamide Transport Inhibitors$772,606
R01 · FY2017 · DA · contact PI
FABPs: Novel Roles in Pain and Inflammation$353,314
R01 · FY2017 · DA · contact PI
FABPs: Novel Roles in Pain and Inflammation$349,780
R01 · FY2016 · DA · contact PI
FABPs: Novel Roles in Pain and Inflammation$348,014
R01 · FY2015 · DA · contact PI
FABPs: Novel Roles in Pain and Inflammation$353,314
R01 · FY2014 · DA · contact PI
FABPs Mediate Activation of PPAR Alpha Receptors by N-Acylethanolamines$196,250
R21 · FY2012 · DA · contact PI
FABPs Mediate Activation of PPAR Alpha Receptors by N-Acylethanolamines$193,012
R21 · FY2011 · DA · contact PI